Skip to main content
Clinical Trials/ISRCTN30172374
ISRCTN30172374
Completed
Not Applicable

The use of a biologic topical haemostatic agent (TachoSil®) for the prevention of postoperative bleeding in patients on antithrombotic therapy undergoing thyroid surgery: a randomized controlled trial

niversity of Cagliari0 sites70 target enrollmentMarch 30, 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
niversity of Cagliari
Enrollment
70
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 30, 2015
End Date
TBD
Last Updated
9 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversity of Cagliari

Eligibility Criteria

Inclusion Criteria

  • Patients taking vitamin K antagonists (warfarin or acenocoumarol), or acetyl salicylic acid for the prevention of thromboembolism scheduled for open total thyroidectomy

Exclusion Criteria

  • Patients treated with antithrombotic drugs other than vitamin K antagonists (warfarin or acenocoumarol), or scheduled for partial thyroidectomy

Outcomes

Primary Outcomes

Not specified

Similar Trials